BDBM499352 4-((3-(6- (cyclopropylmethoxy)pyridin-3- yl)-4-fluorophenoxy)methyl)-N- (cyclopropylsulfonyl)benzamide::US11020381, Example 43

SMILES Fc1ccc(OCc2ccc(cc2)C(=O)NS(=O)(=O)C2CC2)cc1-c1ccc(OCC2CC2)nc1

InChI Key InChIKey=DDIMYEXMSNZWPT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 499352   

TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Raqualia Pharma

US Patent
LigandPNGBDBM499352(4-((3-(6- (cyclopropylmethoxy)pyridin-3- yl)-4-flu...)
Affinity DataIC50: <500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent